The United Kingdom-based pharma giant, GlaxoSmithKline Pharmaceuticals or GSK's Indian arm GSK Pharmaceuticals, saw its shares continue to rise on Tuesday as well. This is because the company made major gains in the intraday trade on Monday, February 17.

GSk's Giant Profits

This surge in company shares came to pass after the pharma giant reported a monumental rise in its profit after tax. The company's PAT rose multifold, in recently concluded quarter or Q3 of FY25.

In the quarter that ended in December 2024, the company saw its profits surge to Rs 230 crore. This mammoth sum dwarfed the previous fiscal year's profit margin of Rs 46 crore.

The company's total revenue also saw a rise. In the previous year's Q3 or Q3FY24, the total revenue attained by the company stood at Rs 805.26 crore. This rose to Rs 949.42 crore in the span of a year.

GSK Shares Continue To Zoom

When we look at closely at the value of the company shares, and its recent performance, its has made major gains at Dalal Street.

The makers of paediatric vaccines has seen the value of its stock rise by a mammoth 17.14 per cent or Rs 347.55 in the span of the past five trading sessions or a week.

Over the past month of trade, the cumulative gains have risen by Rs 239.95 or 11.24 per cent.

When we look at the company stock's performance today, after mini jitters at the beginning of the day, the value of the company shares carried on, from where it had ended the day, yesterday.

After starting higher than yesterday, at Rs 2,334.05, the shares hit the low point of Rs 2,300.00, only to stage a remarkable recovery.

At the time of writing, the overall gains attained by the pharma shares stood at 1.68 per cent or Rs 39.40, taking the overall value of the company shares to Rs 2,379.65 per piece.